Specific genotypes of human papillomavirus in 125 high-grade squamous lesions and invasive cervical cancer cases from Congolese women

被引:11
|
作者
Boumba, Luc Magloire Anicet [1 ,2 ,3 ]
Hilali, Lahoucine [2 ]
Mouallif, Mustapha [1 ,4 ]
Moukassa, Donatien [3 ]
Ennaji, Moulay Mustapha [1 ]
机构
[1] Univ Hassan II Mohammedia, Fac Sci & Tech, Lab Virol Microbiol & Qual ETB, BP 146, Mohammadia 20650, Morocco
[2] Univ Hassan, Fac Sci & Tech, Dept Biol Appl, Lab Agroalimentaire & Sante, Settat, Morocco
[3] Hop Gen Loandjili, Lab Anal Med & Morphol, Pointe Noire, Rep Congo
[4] Univ Hassan, Inst Super Sci Sante, Settat, Morocco
关键词
Specific-genotype; HPV; HSIL; ICC; Southwestern Congo; PARTICLE VACCINE; HPV; PREVALENCE; RISK; POPULATION; INFECTION; TYPE-18; PERSISTENCE; WORLDWIDE; EFFICACY;
D O I
10.1186/1471-2458-14-1320
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Knowledge on HPV prevalence and genotype distribution in HSIL and ICC is highly essential for the introduction of an effective vaccination program and appropriate epidemiological monitoring of viral ecology before and after vaccination in Congo. This study aimed to determine the specific-HPV genotypes in HSIL and ICC among women in southwestern Congo. Methods: 125 archival paraffin-embedded biopsy collected between 2008 and 2012 and histologically diagnosed were investigated. DNA extraction was performed using the phenol/chloroform method. HPV search was performed by nested-PCR using MY09/MY11 and GP5+/GP6+ consensus primers followed by direct sequencing. Results: The mean age of participants was 44.3 +/- 8.2 years. Overall, HPV prevalence was 89.6% (112/125) with all high-risk genotypes. HPV DNA was detected in 81.5% (53/65) of HSIL and 98.3% (59/60) of ICC. HPV 16 the most common genotype was detected in 47.1% (25/53) of HSIL and 52.5% (31/59) of ICC. Other types identified were: HPV 33 (22.6%), HPV 18 (15%), HPV 31 (11.3%) and HPV 69 (3.7%) in HSIL, and HPV 33 (28.8%), HPV 18 (11.8%), HPV 31 (5%) and HPV 35 (1.7%) in ICC. Knowing that the ADC accounted for 6.7% (4/60) of ICC cases, HPV 18 was identified in 25% (1/4) of these cases against 75% (3/4) for HPV 16. Conclusion: Our study showed that HPV 16, 33, 18 and 31 were the four most common genotypes in women with HSIL and ICC. These findings indicate that current vaccines against HPV could help to reduce the burden of cervical cancer in Congo.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Human papillomavirus (HPV) type distribution in cervical carcinoma low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women
    Correnti, Maria
    Medina, Francisco
    Eugenia Cavazza, Maria
    Rennola, Antonieta
    Avila, Maira
    Fernandes, Andreina
    GYNECOLOGIC ONCOLOGY, 2011, 121 (03) : 527 - 531
  • [22] Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States
    Mix, Jacqueline M.
    Saraiya, Mona
    Thompson, Trevor D.
    Querec, Troy D.
    Greek, April
    Tucker, Thomas C.
    Peters, Edward S.
    Lynch, Charles F.
    Hernandez, Brenda Y.
    Copeland, Glenn
    Goodman, Marc T.
    Unger, Elizabeth R.
    CANCER, 2021, 127 (19) : 3614 - 3621
  • [23] How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions
    Callegari, Emma T.
    Tabrizi, Sepehr N.
    Pyman, Jan
    Saville, Marion
    Cornall, Alyssa M.
    Brotherton, Julia M. L.
    Garland, Suzanne M.
    VACCINE, 2014, 32 (32) : 4082 - 4088
  • [24] Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention
    de la Cour, Cecilie Dovey
    Guleria, Sonia
    Nygard, Mari
    Trygvadottir, Laufey
    Sigurdsson, Kristjan
    Liaw, Kai-Li
    Hortlund, Maria
    Lagheden, Camilla
    Hansen, Bo T.
    Munk, Christian
    Dillner, Joakim
    Kjaer, Susanne K.
    CANCER MEDICINE, 2019, 8 (02): : 839 - 849
  • [25] DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer
    Kim, Mi-Kyung
    Lee, In-Ho
    Lee, Ki-Heon
    Lee, Yoo Kyung
    So, Kyeong A.
    Hong, Sung Ran
    Hwang, Chang-Sun
    Kee, Mee-Kyung
    Rhee, Jee Eun
    Kang, Chun
    Hur, Soo Young
    Park, Jong Sup
    Kim, Tae-Jin
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (02)
  • [26] Human papillomavirus genotype prevalence in high-grade squamous intraepithelial lesions and colposcopically normal women from Zimbabwe
    Gravitt, PE
    Kamath, AM
    Gaffikin, L
    Chirenje, ZM
    Womack, S
    Shah, KV
    INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (06) : 729 - 732
  • [27] Human papillomavirus testing in primary screening of high-grade cervical lesions: A study of 12538 women
    Clavel, C
    Cucherousset, J
    Bory, JP
    Gabriel, R
    Quereux, C
    Birembaut, P
    EUROGIN 2003: 5TH INTERNATIONAL MULTIDISCIPLINARY CONGRESS, 2003, : 47 - 53
  • [28] Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions
    Louvanto, Karolina
    Verhoef, Lisanne
    Pimenoff, Ville
    Eriksson, Tiina
    Leppala, Siiri
    Lagheden, Camilla
    Gray, Penelope
    Scibior-Bentkowska, Dorota
    Sumiec, Elizabeth
    Nieminen, Pekka
    Dillner, Joakim
    Berkhof, Johannes
    Meijer, Chris J. L. M.
    Lehtinen, Matti
    Nedjai, Belinda
    Heideman, Danielle A. M.
    INTERNATIONAL JOURNAL OF CANCER, 2024,
  • [29] Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil
    Cristina Mendes de Oliveira
    José Humberto Tavares Guerreiro Fregnani
    Jesus Paula Carvalho
    Adhemar Longatto-Filho
    José Eduardo Levi
    BMC Cancer, 13
  • [30] Association of human papillomavirus and bacterial vaginosis with increased risk of high-grade squamous intraepithelial cervical lesions
    Suehiro, Tamy Tiemi
    Malaguti, Natalia
    Damke, Edilson
    Uchimura, Nelson Shozo
    Gimenes, Fabricia
    Souza, Raquel Pantarotto
    Sela da Silva, Vania Ramos
    Lopes Consolaro, Marcia Edilaine
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (02) : 242 - 249